Kymera Therapeutics, Inc. — 10-Q Filings
16 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Kymera Therapeutics, Inc. (KYMR), sorted by most recent first. Each row links to the full filing on EdgarLookup. Kymera Therapeutics, Inc. has filed 16 10-Q documents with the SEC since 2020. To view all SEC filings by Kymera Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-263550 | Nov 4, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-106229 | Aug 11, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-067498 | May 9, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-119249 | Oct 31, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-092275 | Aug 7, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-051567 | May 2, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-057743 | Nov 2, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-037581 | Aug 3, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-017462 | May 4, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-021543 | Nov 3, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-015745 | Aug 9, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-006947 | May 3, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-003911 | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-041902 | Aug 6, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-024514 | May 6, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001564590-20-050872 | Nov 5, 2020 | Sep 30, 2020 |